2024-07-28 12:08:49
The Ministry of Health of the Community of Madrid has reported that the man who was admitted to the La Paz University Hospital for Crimean-Congo hemorrhagic fever (CHFCC) died this Saturday. A 74-year-old man who went to the Emergency Room of the Rey Juan Carlos Hospital on July 19 with a general condition. Days before he had suffered a sign in the area of Buenasbodas, in Toledo.
This disease has already caused other cases in Spain. In fact, in Madrid there was the first non-imported Western European large from other world regions. It happened in September 2016, it started from a sign from Ávila. And it affects not only the patient, but also the professional who treats him.
After this case, the presence of the virus was recorded in the signs taken on wild animals in the areas of the seven regions of the study of the Autonomous Regions. Extremadura, Castilla-La Mancha, Castilla y León and Madrid.
What is Crimean-Congo fever and how is it spread?
As a result of the new case, the director general of Public Health, Laura Ruiz, has revealed that the Crimean-Congo hemorrhagic fever is a viral disease that spreads widely. usually about ticksespecially one called Hyalomma, of African origin.
According to WHO, the rate of The fatality rate of CCHF outbreaks can reach 40%. And there is no vaccine available for humans or animals.
It cannot be spread by eating it alone. It can turn out kind of contact with animal disease. And transmission between people can happen when constant close contact with blood, secretions, organs, or other body fluids of those who are sick. Infections also occur as a result of poor sanitation of medical equipment, reuse of needles, and contamination of medical supplies.
The virus belongs to the ‘Nairoviridae’ family and is endemic to Africa, Asia, Eastern Europe and the Middle East. The WHO explains that, although there are many signs that can be infected by the CCHF virus, Hyalomma is the main vector.
Symptoms
If it is due to being a sign, The incubation period is generally one to three days, maximum nine. In the case of contact with blood or infected tissues is usually five or six days, with a maximum of 13 days.
The symptoms appeared suddenly, including fever, muscle pain, dizziness, neck stiffness, headache, eye irritation, photophobia and mild pain. In addition, nausea, diarrhea, vomiting and sore throat may occur first, as well as confusion. After two to four days, this depression progresses to depression, fatigue, abdominal pain and feeling weak.
WHO also indicated that other clinical signs are tachycardia, bleeding skin on internal mucous membranes, for example in the mouth, throat or skin, which may increase, and lymphatic inflammation.
Signs of hepatitis often occur, and The deterioration of the most critical patients can be very rapid manifested from liver failure to pulmonary failure from the fifth day of illness.
recommendations
The Director General of Public Health has indicated that we must try not to go to the countryside, and if that happens or travel activities, it is necessary. use repellers. And after the trip check your clothes, hair and body.
You also have advice dress in light color clothes, and with long sleeves and pants. Avoid shoes, and wear socks over pants. And if you come with a pet, it would be advisable to protect them with the appropriate repellents for them.
However, WHO shows that it is difficult to prevent or control infection in animals and ticks, because both animal ticks and infection of domestic animals are often not noticed. Among other things, because the ticks that can act as pollinators are numerous and widespread, “so their fight with acaricides, which are chemical products that kill them, is only A viable option is meat products well managed,” they said.
Diagnosed
It is done through laboratory tests that detect the virus or antibodies against the virus in the patient’s blood.
Treatment
As WHO explains There is no specific antiviral treatment. General supportive care against symptoms is the first option in these cases. It has been used antiviral ribavirin to treat the infection, with clear beneficial effects.
And although an inactivated mouse brain vaccine against CCHF has been developed and used on a small scale in Eastern Europe, there is currently no safe and effective vaccine widely available for human use.
“In the absence of a vaccine, it is the only way to reduce human infection knowledge of risk factors and education of the population about measures that can be taken to reduce exposure to the virus.
#CrimeanCongo #hemorrhagic #fever #symptoms #transmission #recommendations